Lynx Capital Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Lynx Capital Group's MRK Position: Q2 2026 in Review
Lynx Capital Group reduced its Merck (MRK) stake by 0.27% in Q2 2026, selling an estimated $8.78K and leaving 27,879 shares worth $3.58M. The position accounts for 1.45% of the portfolio, ranked #33.
Lynx Capital Group first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. 3,688 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Lynx Capital Group held 27,879 shares of Merck worth $3.58M as of Q2 2026.
- Lynx Capital Group sold 75 Merck shares in Q2 2026, an estimated $8.78K.
- Merck made up 1.45% of Lynx Capital Group's portfolio in Q2 2026, its #33 holding.
- Lynx Capital Group first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
- 3,688 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Lynx Capital Group's 13F filing for Q2 2026, filed 12 Aug 2026.